KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Work In Process (2016 - 2020)

Historic Work In Process for Emergent BioSolutions (EBS) over the last 11 years, with Q1 2020 value amounting to $114.2 million.

  • Emergent BioSolutions' Work In Process changed N/A to $114.2 million in Q1 2020 from the same period last year, while for Mar 2020 it was $114.2 million, marking a year-over-year change of. This contributed to the annual value of $89.7 million for FY2019, which is 1308.14% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Work In Process of $114.2 million as of Q1 2020.
  • Over the past 5 years, Emergent BioSolutions' Work In Process peaked at $119.1 million during Q2 2019, and registered a low of $14.8 million during Q3 2017.
  • In the last 5 years, Emergent BioSolutions' Work In Process had a median value of $70.7 million in 2017 and averaged $64.5 million.
  • Its Work In Process has fluctuated over the past 5 years, first crashed by 3958.87% in 2017, then skyrocketed by 33871.82% in 2018.
  • Emergent BioSolutions' Work In Process (Quarter) stood at $19.8 million in 2016, then surged by 286.46% to $76.6 million in 2017, then soared by 34.73% to $103.2 million in 2018, then dropped by 13.08% to $89.7 million in 2019, then grew by 27.31% to $114.2 million in 2020.
  • Its Work In Process was $114.2 million in Q1 2020, compared to $89.7 million in Q4 2019 and $106.6 million in Q3 2019.